chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: had the vaccine in February and the magnet sticking to vaccination site today 27May2021; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (had the vaccine in February and the magnet sticking to vaccination site today 27May2021) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (had the vaccine in February and the magnet sticking to vaccination site today 27May2021). At the time of the report, VACCINATION SITE REACTION (had the vaccine in February and the magnet sticking to vaccination site today 27May2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: transient numbness and loss of feeling in both hands; This spontaneous case was reported by an other health care professional and describes the occurrence of HYPOAESTHESIA (transient numbness and loss of feeling in both hands) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-May-2021, the patient experienced HYPOAESTHESIA (transient numbness and loss of feeling in both hands). At the time of the report, HYPOAESTHESIA (transient numbness and loss of feeling in both hands) had resolved.            Patient went to the ER and was undergoing test.  No concomitant information was reported.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Event Outcome Reported
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: mild fever; Diarrhea; weak; soreness around injection site; headache; chills; body aches; fatigued; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (Diarrhea), ASTHENIA (weak), VACCINATION SITE PAIN (soreness around injection site), HEADACHE (headache) and CHILLS (chills) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced FATIGUE (fatigued). On 26-May-2021, the patient experienced DIARRHOEA (Diarrhea), ASTHENIA (weak), VACCINATION SITE PAIN (soreness around injection site), HEADACHE (headache), CHILLS (chills) and MYALGIA (body aches). On an unknown date, the patient experienced PYREXIA (mild fever). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. On 27-May-2021, DIARRHOEA (Diarrhea), ASTHENIA (weak), VACCINATION SITE PAIN (soreness around injection site), HEADACHE (headache), CHILLS (chills), MYALGIA (body aches), FATIGUE (fatigued) and PYREXIA (mild fever) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No reported concomitant medications.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.   This case was linked to MOD-2021-182943 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: mild fever; Diarrhea; weak; soreness around injection site; headache; chills; body aches; fatigued; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (Diarrhea), ASTHENIA (weak), VACCINATION SITE PAIN (soreness around injection site), HEADACHE (headache) and CHILLS (chills) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced FATIGUE (fatigued). On 26-May-2021, the patient experienced DIARRHOEA (Diarrhea), ASTHENIA (weak), VACCINATION SITE PAIN (soreness around injection site), HEADACHE (headache), CHILLS (chills) and MYALGIA (body aches). On an unknown date, the patient experienced PYREXIA (mild fever). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. On 27-May-2021, DIARRHOEA (Diarrhea), ASTHENIA (weak), VACCINATION SITE PAIN (soreness around injection site), HEADACHE (headache), CHILLS (chills), MYALGIA (body aches), FATIGUE (fatigued) and PYREXIA (mild fever) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No reported concomitant medications.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.   This case was linked to MOD-2021-182943 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Sex: M
Vaccine: COVID19
Symptoms: Fall, Limb injury
Clinical narrative: Suffered a fall; Hurt my right leg; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FALL (Suffered a fall) and LIMB INJURY (Hurt my right leg) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, the patient experienced FALL (Suffered a fall) and LIMB INJURY (Hurt my right leg). The patient was treated with CHYMOTRYPSIN, RIBONUCLEASE, TRYPSIN (RIBATRAN) at a dose of UNK, tid; ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE (GENACID) (oral) at a dose of UNK, tid and DICLOFENAC DIETHYLAMINE (VOLTAREN [DICLOFENAC DIETHYLAMINE]) at a dose of UNK, tid. At the time of the report, FALL (Suffered a fall) and LIMB INJURY (Hurt my right leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. Patient reports that as he was going up some stairs, there was some kind of liquid on the stairs & he slipped.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Musculoskeletal pain, Myalgia
Clinical narrative: pain in bottoms left side and pain in both shoulders; pain in arms when lifting up arm and pain in both shoulder; Pain in bottoms left side; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (pain in bottoms left side and pain in both shoulders), MYALGIA (pain in arms when lifting up arm and pain in both shoulder) and MUSCULOSKELETAL PAIN (Pain in bottoms left side) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. U36B21A and 022C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, METOPROLOL, AMLODIPINE and ROSUVASTATIN for an unknown indication.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced MUSCULOSKELETAL PAIN (Pain in bottoms left side). On an unknown date, the patient experienced ARTHRALGIA (pain in bottoms left side and pain in both shoulders) and MYALGIA (pain in arms when lifting up arm and pain in both shoulder). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency; IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency; NAPROXEN SODIUM (ALEVE) ongoing since an unknown date at an unspecified dose and frequency and MELOXICAM (oral) ongoing since an unknown date at a dose of 7.5 mg. At the time of the report, ARTHRALGIA (pain in bottoms left side and pain in both shoulders), MYALGIA (pain in arms when lifting up arm and pain in both shoulder) and MUSCULOSKELETAL PAIN (Pain in bottoms left side) had not resolved.            Concomitant medications included hydrochloro as reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: TCR received on 9-JUN-2021 contains no new information. On 14-Jun-2021: Follow up received on 14-JUN-2021 contains Meloxicam 7.5 mg as new treatment drug
Sex: U
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: 1st dose was Moderna, 2nd dose was Johnson and Johnson.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (1st dose was Moderna, 2nd dose was Johnson and Johnson.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (1st dose was Moderna, 2nd dose was Johnson and Johnson.). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (1st dose was Moderna, 2nd dose was Johnson and Johnson.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: vaccination site swelling; Injection site is itchy; Raised rash at injection site; vaccination site erythema; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site is itchy), VACCINATION SITE RASH (Raised rash at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Raised rash at injection site) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003CZIA) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 17-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site is itchy), VACCINATION SITE RASH (Raised rash at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). On an unknown date, the patient experienced VACCINATION SITE SWELLING (Raised rash at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Injection site is itchy), VACCINATION SITE RASH (Raised rash at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Raised rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication included.  Treatment medication like BENADRYL was included.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: Several small lumps on my arm below where I got the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Several small lumps on my arm below where I got the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Several small lumps on my arm below where I got the vaccine). At the time of the report, VACCINATION SITE MASS (Several small lumps on my arm below where I got the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were not reported.  The treatment information was not provided.   Reporter did not allow further contact
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Illness, Product dose omission issue
Clinical narrative: Got sick; Missed his second series; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Got sick) and PRODUCT DOSE OMISSION ISSUE (Missed his second series) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Got sick) and PRODUCT DOSE OMISSION ISSUE (Missed his second series). At the time of the report, ILLNESS (Got sick) and PRODUCT DOSE OMISSION ISSUE (Missed his second series) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications and treatment information was not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Mobility decreased, Swelling, Vaccination site pain
Clinical narrative: swelling; cant lift my arm to shoulder level; sore arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), MOBILITY DECREASED (cant lift my arm to shoulder level) and VACCINATION SITE PAIN (sore arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-May-2021 at 12:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (swelling), MOBILITY DECREASED (cant lift my arm to shoulder level) and VACCINATION SITE PAIN (sore arm). At the time of the report, SWELLING (swelling), MOBILITY DECREASED (cant lift my arm to shoulder level) and VACCINATION SITE PAIN (sore arm) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: Dizziness; Brain fog; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and FEELING ABNORMAL (Brain fog) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness) and FEELING ABNORMAL (Brain fog). At the time of the report, DIZZINESS (Dizziness) and FEELING ABNORMAL (Brain fog) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided No treatment medication provided. The patient stated that the events of first dose went away after 3 or 4 days.   This case was linked to MOD-2021-183128 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received Expired Dose of Vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine). On 25-May-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication history not provided.
Sex: U
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy
Clinical narrative: painful swelling; Painful swelling in my Underarm; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (painful swelling) and LYMPHADENOPATHY (Painful swelling in my Underarm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AXILLARY PAIN (painful swelling) and LYMPHADENOPATHY (Painful swelling in my Underarm). At the time of the report, AXILLARY PAIN (painful swelling) and LYMPHADENOPATHY (Painful swelling in my Underarm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details were reported. Concomitant medication were not reported
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Cough, Diarrhoea, Dizziness, Dyspnoea
Clinical narrative: Dizziness; Brain fog; fast heart beat; shortness of breath; chronic migraine; stomach pain; diarrhea; chronic cough; high blood pressure; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), FEELING ABNORMAL (Brain fog), HEART RATE INCREASED (fast heart beat), DYSPNOEA (shortness of breath) and MIGRAINE (chronic migraine) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02821A and 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced DIZZINESS (Dizziness), FEELING ABNORMAL (Brain fog), HEART RATE INCREASED (fast heart beat), DYSPNOEA (shortness of breath), MIGRAINE (chronic migraine), ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (diarrhea), COUGH (chronic cough), HYPERTENSION (high blood pressure) and NAUSEA (nausea). The patient was treated with ALBUTEROL [SALBUTAMOL] at an unspecified dose and frequency and LORATADINE at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), FEELING ABNORMAL (Brain fog), HEART RATE INCREASED (fast heart beat), DYSPNOEA (shortness of breath), MIGRAINE (chronic migraine), ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (diarrhea), COUGH (chronic cough), HYPERTENSION (high blood pressure) and NAUSEA (nausea) outcome was unknown.            No concomitants were reported.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.    This case was linked to MOD-2021-183075 (Patient Link).
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Heart rate increased, Hypertension, Migraine, Nausea
Clinical narrative: Dizziness; Brain fog; fast heart beat; shortness of breath; chronic migraine; stomach pain; diarrhea; chronic cough; high blood pressure; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), FEELING ABNORMAL (Brain fog), HEART RATE INCREASED (fast heart beat), DYSPNOEA (shortness of breath) and MIGRAINE (chronic migraine) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02821A and 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced DIZZINESS (Dizziness), FEELING ABNORMAL (Brain fog), HEART RATE INCREASED (fast heart beat), DYSPNOEA (shortness of breath), MIGRAINE (chronic migraine), ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (diarrhea), COUGH (chronic cough), HYPERTENSION (high blood pressure) and NAUSEA (nausea). The patient was treated with ALBUTEROL [SALBUTAMOL] at an unspecified dose and frequency and LORATADINE at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), FEELING ABNORMAL (Brain fog), HEART RATE INCREASED (fast heart beat), DYSPNOEA (shortness of breath), MIGRAINE (chronic migraine), ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (diarrhea), COUGH (chronic cough), HYPERTENSION (high blood pressure) and NAUSEA (nausea) outcome was unknown.            No concomitants were reported.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.    This case was linked to MOD-2021-183075 (Patient Link).
Age: 59.0
Sex: U
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: test positive for covid; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (test positive for covid) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Prediabetes.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SARS-COV-2 TEST POSITIVE (test positive for covid). At the time of the report, SARS-COV-2 TEST POSITIVE (test positive for covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       In concomitant medications hypertension medications were reported. Treatment details were Lemon water and tea with lemon reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint lock
Clinical narrative: Pain in the knees and cannot bend them; Pain in the knees and cannot bend them; This spontaneous case was reported by a consumer and describes the occurrence of JOINT LOCK (Pain in the knees and cannot bend them) and ARTHRALGIA (Pain in the knees and cannot bend them) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 013L20A) for COVID-19 immunisation.     No medical history was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced JOINT LOCK (Pain in the knees and cannot bend them) and ARTHRALGIA (Pain in the knees and cannot bend them). At the time of the report, JOINT LOCK (Pain in the knees and cannot bend them) and ARTHRALGIA (Pain in the knees and cannot bend them) outcome was unknown.            Concomitant medications include Blood pressure medication and Cholesterol medication. No treatment was reported. The action taken with  mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) was not applicable and reporter didn't provide causality assessment.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Dehydration, Dyspnoea, Fatigue, Hyperhidrosis
Clinical narrative: Lymph node; arm hurting; vomiting; so tired; hard to breathe in; cannot move arm with injection site; numb; giant lumps; cannot jog; cannot see; sweating; back hurts; back of throat is not normal; constantly dehydrated; bumps on tongue; cannot think; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (hard to breathe in), INJECTION SITE MOVEMENT IMPAIRMENT (cannot move arm with injection site), HYPOAESTHESIA (numb), SWELLING (giant lumps) and MOBILITY DECREASED (cannot jog) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Kidney disorder (PATIENT REPORTED AS KIDNEY PROBLEM.) and Heart murmur. Concurrent medical conditions included Sinusitis and Penicillin allergy.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced DYSPNOEA (hard to breathe in), INJECTION SITE MOVEMENT IMPAIRMENT (cannot move arm with injection site), HYPOAESTHESIA (numb), SWELLING (giant lumps), MOBILITY DECREASED (cannot jog), VISUAL IMPAIRMENT (cannot see), HYPERHIDROSIS (sweating), BACK PAIN (back hurts), OROPHARYNGEAL DISCOMFORT (back of throat is not normal), DEHYDRATION (constantly dehydrated), TONGUE ERUPTION (bumps on tongue), THINKING ABNORMAL (cannot think), MYALGIA (arm hurting), VOMITING (vomiting) and FATIGUE (so tired). On an unknown date, the patient experienced LYMPHADENOPATHY (Lymph node). At the time of the report, DYSPNOEA (hard to breathe in), INJECTION SITE MOVEMENT IMPAIRMENT (cannot move arm with injection site), HYPOAESTHESIA (numb), SWELLING (giant lumps), MOBILITY DECREASED (cannot jog), VISUAL IMPAIRMENT (cannot see), HYPERHIDROSIS (sweating), BACK PAIN (back hurts), OROPHARYNGEAL DISCOMFORT (back of throat is not normal), DEHYDRATION (constantly dehydrated), TONGUE ERUPTION (bumps on tongue), THINKING ABNORMAL (cannot think), LYMPHADENOPATHY (Lymph node), MYALGIA (arm hurting), VOMITING (vomiting) and FATIGUE (so tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs include Vitamins and supplements. No treatment details were provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site movement impairment, Lymphadenopathy, Mobility decreased, Myalgia
Clinical narrative: Lymph node; arm hurting; vomiting; so tired; hard to breathe in; cannot move arm with injection site; numb; giant lumps; cannot jog; cannot see; sweating; back hurts; back of throat is not normal; constantly dehydrated; bumps on tongue; cannot think; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (hard to breathe in), INJECTION SITE MOVEMENT IMPAIRMENT (cannot move arm with injection site), HYPOAESTHESIA (numb), SWELLING (giant lumps) and MOBILITY DECREASED (cannot jog) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Kidney disorder (PATIENT REPORTED AS KIDNEY PROBLEM.) and Heart murmur. Concurrent medical conditions included Sinusitis and Penicillin allergy.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced DYSPNOEA (hard to breathe in), INJECTION SITE MOVEMENT IMPAIRMENT (cannot move arm with injection site), HYPOAESTHESIA (numb), SWELLING (giant lumps), MOBILITY DECREASED (cannot jog), VISUAL IMPAIRMENT (cannot see), HYPERHIDROSIS (sweating), BACK PAIN (back hurts), OROPHARYNGEAL DISCOMFORT (back of throat is not normal), DEHYDRATION (constantly dehydrated), TONGUE ERUPTION (bumps on tongue), THINKING ABNORMAL (cannot think), MYALGIA (arm hurting), VOMITING (vomiting) and FATIGUE (so tired). On an unknown date, the patient experienced LYMPHADENOPATHY (Lymph node). At the time of the report, DYSPNOEA (hard to breathe in), INJECTION SITE MOVEMENT IMPAIRMENT (cannot move arm with injection site), HYPOAESTHESIA (numb), SWELLING (giant lumps), MOBILITY DECREASED (cannot jog), VISUAL IMPAIRMENT (cannot see), HYPERHIDROSIS (sweating), BACK PAIN (back hurts), OROPHARYNGEAL DISCOMFORT (back of throat is not normal), DEHYDRATION (constantly dehydrated), TONGUE ERUPTION (bumps on tongue), THINKING ABNORMAL (cannot think), LYMPHADENOPATHY (Lymph node), MYALGIA (arm hurting), VOMITING (vomiting) and FATIGUE (so tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs include Vitamins and supplements. No treatment details were provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort, Swelling, Thinking abnormal, Tongue eruption, Visual impairment
Clinical narrative: Lymph node; arm hurting; vomiting; so tired; hard to breathe in; cannot move arm with injection site; numb; giant lumps; cannot jog; cannot see; sweating; back hurts; back of throat is not normal; constantly dehydrated; bumps on tongue; cannot think; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (hard to breathe in), INJECTION SITE MOVEMENT IMPAIRMENT (cannot move arm with injection site), HYPOAESTHESIA (numb), SWELLING (giant lumps) and MOBILITY DECREASED (cannot jog) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Kidney disorder (PATIENT REPORTED AS KIDNEY PROBLEM.) and Heart murmur. Concurrent medical conditions included Sinusitis and Penicillin allergy.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced DYSPNOEA (hard to breathe in), INJECTION SITE MOVEMENT IMPAIRMENT (cannot move arm with injection site), HYPOAESTHESIA (numb), SWELLING (giant lumps), MOBILITY DECREASED (cannot jog), VISUAL IMPAIRMENT (cannot see), HYPERHIDROSIS (sweating), BACK PAIN (back hurts), OROPHARYNGEAL DISCOMFORT (back of throat is not normal), DEHYDRATION (constantly dehydrated), TONGUE ERUPTION (bumps on tongue), THINKING ABNORMAL (cannot think), MYALGIA (arm hurting), VOMITING (vomiting) and FATIGUE (so tired). On an unknown date, the patient experienced LYMPHADENOPATHY (Lymph node). At the time of the report, DYSPNOEA (hard to breathe in), INJECTION SITE MOVEMENT IMPAIRMENT (cannot move arm with injection site), HYPOAESTHESIA (numb), SWELLING (giant lumps), MOBILITY DECREASED (cannot jog), VISUAL IMPAIRMENT (cannot see), HYPERHIDROSIS (sweating), BACK PAIN (back hurts), OROPHARYNGEAL DISCOMFORT (back of throat is not normal), DEHYDRATION (constantly dehydrated), TONGUE ERUPTION (bumps on tongue), THINKING ABNORMAL (cannot think), LYMPHADENOPATHY (Lymph node), MYALGIA (arm hurting), VOMITING (vomiting) and FATIGUE (so tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs include Vitamins and supplements. No treatment details were provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Lymph node; arm hurting; vomiting; so tired; hard to breathe in; cannot move arm with injection site; numb; giant lumps; cannot jog; cannot see; sweating; back hurts; back of throat is not normal; constantly dehydrated; bumps on tongue; cannot think; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (hard to breathe in), INJECTION SITE MOVEMENT IMPAIRMENT (cannot move arm with injection site), HYPOAESTHESIA (numb), SWELLING (giant lumps) and MOBILITY DECREASED (cannot jog) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Kidney disorder (PATIENT REPORTED AS KIDNEY PROBLEM.) and Heart murmur. Concurrent medical conditions included Sinusitis and Penicillin allergy.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced DYSPNOEA (hard to breathe in), INJECTION SITE MOVEMENT IMPAIRMENT (cannot move arm with injection site), HYPOAESTHESIA (numb), SWELLING (giant lumps), MOBILITY DECREASED (cannot jog), VISUAL IMPAIRMENT (cannot see), HYPERHIDROSIS (sweating), BACK PAIN (back hurts), OROPHARYNGEAL DISCOMFORT (back of throat is not normal), DEHYDRATION (constantly dehydrated), TONGUE ERUPTION (bumps on tongue), THINKING ABNORMAL (cannot think), MYALGIA (arm hurting), VOMITING (vomiting) and FATIGUE (so tired). On an unknown date, the patient experienced LYMPHADENOPATHY (Lymph node). At the time of the report, DYSPNOEA (hard to breathe in), INJECTION SITE MOVEMENT IMPAIRMENT (cannot move arm with injection site), HYPOAESTHESIA (numb), SWELLING (giant lumps), MOBILITY DECREASED (cannot jog), VISUAL IMPAIRMENT (cannot see), HYPERHIDROSIS (sweating), BACK PAIN (back hurts), OROPHARYNGEAL DISCOMFORT (back of throat is not normal), DEHYDRATION (constantly dehydrated), TONGUE ERUPTION (bumps on tongue), THINKING ABNORMAL (cannot think), LYMPHADENOPATHY (Lymph node), MYALGIA (arm hurting), VOMITING (vomiting) and FATIGUE (so tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs include Vitamins and supplements. No treatment details were provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: feels like two hooks are at the rear/base of the skull and is having intense headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (feels like two hooks are at the rear/base of the skull and is having intense headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 011L20) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) and XYLOMETAZOLINE HYDROCHLORIDE (NASAL SPRAY II) for Allergy, INTRAUTERINE CONTRACEPTIVE DEVICE (IUD NOS) for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (feels like two hooks are at the rear/base of the skull and is having intense headaches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, HEADACHE (feels like two hooks are at the rear/base of the skull and is having intense headaches) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown route) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: numbness if injection arm and face; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness if injection arm and face) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness if injection arm and face). At the time of the report, HYPOAESTHESIA (numbness if injection arm and face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Sex: U
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: vertigo; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (vertigo). At the time of the report, VERTIGO (vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported. No treatment was reported.
Sex: F
Vaccine: COVID19
Symptoms: Diplopia, Dizziness
Clinical narrative: Patient is having double vision after the 2nd dose; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIPLOPIA (Patient is having double vision after the 2nd dose) and DIZZINESS (Dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIPLOPIA (Patient is having double vision after the 2nd dose) and DIZZINESS (Dizziness). At the time of the report, DIPLOPIA (Patient is having double vision after the 2nd dose) and DIZZINESS (Dizziness) outcome was unknown.            No concomitants were reported. No treatment  was reported. The action taken with of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) was not applicable, reporter didn't provide causality assessment.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: How long do side effects last; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (How long do side effects last) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (How long do side effects last). At the time of the report, ADVERSE EVENT (How long do side effects last) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details were reported. Concomitant medications were not reported
Sex: U
Vaccine: COVID19
Symptoms: Feeling hot, Induration, Pruritus, Vaccination site pain
Clinical narrative: a hard area feels rough to the touch/feels like something hard and bumpy under skin; Iches; its a hard area itches and a little warn to touch; Had a small sore place afterward; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INDURATION (a hard area feels rough to the touch/feels like something hard and bumpy under skin), PRURITUS (Iches), FEELING HOT (its a hard area itches and a little warn to touch) and VACCINATION SITE PAIN (Had a small sore place afterward) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INDURATION (a hard area feels rough to the touch/feels like something hard and bumpy under skin), PRURITUS (Iches), FEELING HOT (its a hard area itches and a little warn to touch) and VACCINATION SITE PAIN (Had a small sore place afterward). At the time of the report, INDURATION (a hard area feels rough to the touch/feels like something hard and bumpy under skin), PRURITUS (Iches), FEELING HOT (its a hard area itches and a little warn to touch) and VACCINATION SITE PAIN (Had a small sore place afterward) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pain
Clinical narrative: Pain; Chills; Body aches; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Fatigue) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN (Pain), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Fatigue). At the time of the report, PAIN (Pain), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants were reported. No treatment was reported.   This case was linked to MOD-2021-183220 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: 6 other people who have the same exact symptoms as hers; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of ADVERSE EVENT (6 other people who have the same exact symptoms as hers) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (6 other people who have the same exact symptoms as hers). At the time of the report, ADVERSE EVENT (6 other people who have the same exact symptoms as hers) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication provided. No concomitant medication provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: follow-up email added and No new information is provided